Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0001564590-21-023910 General Corporate
Debt relative to revenue 57th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.debt_to_revenue
135.27% · OPTIONAL · VALID
Capex intensity 7th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.75% · OPTIONAL · VALID
Operating cash generation 43th Own-history percentile · N=14
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
7.72% · OPTIONAL · VALID
Revenue growth 90th Own-history percentile · N=10
Evidence method Yoy · gp.fundamentals.revenue
18.59% · CORE · VALID
Inventory pressure 29th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
51.78% · OPTIONAL · VALID
Gross margin 93th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.gross_margin
25.42% · CORE · VALID
Operating margin 93th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.operating_margin
15.20% · CORE · VALID
R&D intensity 7th Own-history percentile · N=14
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.78% · OPTIONAL · VALID
SBC intensity 86th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.71% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 148.26%
Current 135.27%
Delta -12.98% Capex Intensity Increased
Previous 3.89%
Current 4.75%
Delta 0.86% Cash Generation Increased
Previous 2.81%
Current 7.72%
Delta 4.90% Growth Increased
Previous 2.61%
Current 18.59%
Delta 15.98% Inventory Pressure Decreased
Previous 54.02%
Current 51.78%
Delta -2.24% Margin Decreased
Previous 25.87%
Current 25.42%
Delta -0.46% Profitability Decreased
Previous 15.82%
Current 15.20%
Delta -0.62% R And D Intensity Decreased
Previous 1.88%
Current 1.78%
Delta -0.10% Sbc Intensity Increased
Previous 0.54%
Current 0.71%
Delta 0.18% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.